A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. Reply

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	e8
Journal	New England Journal of Medicine
Volume	383
Issue number	2
DOIs	https://doi.org/10.1056/NEJMc2017351
State	Published - 9 Jul 2020

Access to Document

@article{3fd8566bbdbe4fbb91b1d29844c2e8a8,

title = "A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. Reply",

author = "Dangas, \{George D.\} and \{De Backer\}, Ole and Stephan Windecker",

year = "2020",

month = jul,

day = "9",

doi = "10.1056/NEJMc2017351",

language = "English",

volume = "383",

pages = "e8",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "2",

}

TY - JOUR

T1 - A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. Reply

AU - Dangas, George D.

AU - De Backer, Ole

AU - Windecker, Stephan

PY - 2020/7/9

Y1 - 2020/7/9

UR - https://www.scopus.com/pages/publications/85087695492

U2 - 10.1056/NEJMc2017351

DO - 10.1056/NEJMc2017351

M3 - Letter

C2 - 32640145

AN - SCOPUS:85087695492

SN - 0028-4793

VL - 383

SP - e8

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 2

ER -